Healthy Volunteers Clinical Trial
Official title:
Evaluation of Assessments of Motor Performance, Physical Impairments and Functional Abilities
| Verified date | April 7, 2017 |
| Source | National Institutes of Health Clinical Center (CC) |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This study will evaluate new assessment tools and equipment and new ways of using existing
tools and equipment in the NIH Clinical Center s Rehabilitation Medicine Department in order
to maximize patients function. The Department assesses and treats NIH patients with chronic
pain, problems in walking or getting around, activities of daily living, performing tasks
needed for jobs or hobbies, communicating and chewing and swallowing.
Children and adults of all ages with disabilities and healthy normal volunteers may be
eligible for this study.
The following kinds of assessments are evaluated in this study:
Assessments of Impairments
Impairments are problems such as loss of movement, weakness or loss of sensation. Assessments
may include measurements of range of motion, strength, sensation, pain, joint stability or
mobility, joint angles, limb and girth, gait, exercise tolerance, stamina, or ultrasound
imaging of muscle and swallowing function.
Assessments of Function and Performance
Functional and performance assessments look at how well subjects perform actions, such as
walking or getting around, dressing, or preparing meals. They may include evaluations of
activities of daily living, leisure activities, fatigue, vocational activity, school
activity, coping skills, and quality of life. The assessments may be done by questionnaires
or interviews and by watching subjects perform the activities.
Assessments of Treatment Techniques
Treatment techniques are assessed by evaluating methods and equipment used to treat patients
with impairments or problems with function. They may evaluate, for example, the use of heat,
cold, strengthening exercises, fitness exercises, TENS units, splinting and orthotics, or
shoe modifications.
| Status | Terminated |
| Enrollment | 29 |
| Est. completion date | April 7, 2017 |
| Est. primary completion date | |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
- INCLUSION CRITERIA: Inclusion criteria for subjects with disabilities To participate in projects in this study, subjects with disabilities must: - have a disability appropriate to the measure being assessed - be clinically stable and medically able to tolerate the measure to be evaluated in a specific project in which they are to be enrolled - be an adult able to give informed consent or, if a minor, have a parent/guardian able to provide informed consent - be at least 2 years of age, with no upper age limit Inclusion criteria for healthy volunteers To participate in projects in this study, healthy volunteers must: - be an adult able to provide informed consent or, if a minor, have a parent/guardian able to provide informed consent - be in good general health and have no disability - be able medically able to tolerate the measure to be evaluated in the specific project in which they are to be enrolled - be at least 2 years of age, with no upper age limit EXCLUSION CRITERIA: Exclusion criteria for subjects with disabilities - Have limitations relating to their disability that could result in pain or injury on attempt to use the device or participate in the measure being evaluated in the specific project in the study - Are unable to understand the instructions required to safely use the device or participate in the measure being evaluated - Have a medical or other device in or on their body which may interfere the research assessments. - Have a medical or other device in or on their body that places them at increased risk from use of any device to be evaluated, based on manufacturer s recommendations or accepted medical literature - Have any medical condition which contraindicates use of the specific device to be evaluated, based on manufacturer s recommendations or accepted medical literature. Exclusion criteria for healthy volunteers - Are discovered to have a previously undiagnosed impairment or disability in the domain to be evaluated by the device or measure to be used in the specific project in the study - Are unable to understand the instructions required to safely use the device or participate in the measure being evaluated. - Have a medical or other device in or on their body which may interfere the research assessments. - Have a medical or other device in or on their body that places them at increased risk from use of any device to be evaluated, based on manufacturer s recommendations or accepted medical literature - Have any medical condition which contraindicates use of the specific device to be evaluated, based on manufacturer s recommendations or accepted medical literature - RMD special volunteers, employees and contractors will not be able to participate in this protocol. |
| Country | Name | City | State |
|---|---|---|---|
| United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
| Lead Sponsor | Collaborator |
|---|---|
| National Institutes of Health Clinical Center (CC) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | To evaluate use of clinical assessments/equipment | Ongoing |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |